Literature DB >> 28116678

Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion.

Kapilkumar Vithani1, Adrian Hawley2, Vincent Jannin3, Colin Pouton1, Ben J Boyd4,5.   

Abstract

Solid self-microemulsifying drug delivery systems (SMEDDS) have received considerable attention in recent times attempting to overcome the drawbacks of liquid SMEDDS. Earlier literature reports on solid SMEDDS have focussed on formulation development; however, the digestibility and propensity for self-assembly of the digested components with endogenous bile salts and phospholipids are unknown. Therefore, as a starting point, previously reported solid SMEDDS containing Gelucire® 44/14 (GEL) and the non-digestible surfactants, Vitamin E TPGS (TPGS) and Lutrol® F 127 (F 127), were prepared, and their dispersion and digestion behaviours were studied using an in vitro lipolysis model, coupled with small-angle X-ray scattering (SAXS) to determine the formed colloidal structures during digestion in real time. GEL alone was digested (89%) and formed a lamellar phase (Lα). When surfactants were added at a 40:60% w/w lipid to surfactants ratio, digestion was inhibited with a significant lag time being evident. However, increasing the fraction of GEL to 50% w/w enabled digestion with reduced lag time. The substitution of the non-digestible surfactants with digestible surfactants, sucrose esters S-1670 (S-1670) and Span® 60 (S-60), eliminated the digestion lag time, and the formation of colloidal structures was more similar to that of GEL alone.

Entities:  

Keywords:  in vitro lipolysis; lipid digestion; non-digestible and digestible surfactants; small-angle X-ray scattering; solid SMEDDS

Mesh:

Substances:

Year:  2017        PMID: 28116678     DOI: 10.1208/s12248-016-0036-6

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  51 in total

Review 1.  Solubilizing excipients in oral and injectable formulations.

Authors:  Robert G Strickley
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

2.  Size characterization of commercial micelles and microemulsions by Taylor dispersion analysis.

Authors:  Joseph Chamieh; Florian Davanier; Vincent Jannin; Frédéric Demarne; Hervé Cottet
Journal:  Int J Pharm       Date:  2015-06-30       Impact factor: 5.875

3.  Upper gastrointestinal (GI) pH in young, healthy men and women.

Authors:  J B Dressman; R R Berardi; L C Dermentzoglou; T L Russell; S P Schmaltz; J L Barnett; K M Jarvenpaa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

4.  Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent.

Authors:  M K Gupta; D Goldman; R H Bogner; Y C Tseng
Journal:  Pharm Dev Technol       Date:  2001-11       Impact factor: 3.133

5.  Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules.

Authors:  Xiaohui Mei; Frank M Etzler; Zeren Wang
Journal:  Int J Pharm       Date:  2006-06-13       Impact factor: 5.875

6.  'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.

Authors:  Orlagh M Feeney; Hywel D Williams; Colin W Pouton; Christopher J H Porter
Journal:  J Control Release       Date:  2014-07-22       Impact factor: 9.776

7.  Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design.

Authors:  R Nanda Kishore; Prasanna Raju Yalavarthi; Harini Chowdary Vadlamudi; K R Vandana; Arun Rasheed; M Sushma
Journal:  Drug Dev Ind Pharm       Date:  2014-07-14       Impact factor: 3.225

8.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.

Authors:  S Sethia; E Squillante
Journal:  Int J Pharm       Date:  2004-03-19       Impact factor: 5.875

9.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Agnes Taillardat-Bertschinger; Ben J Boyd; Jacquelyn M O'Connor; Glenn A Edwards; William N Charman
Journal:  J Pharm Sci       Date:  2004-05       Impact factor: 3.534

10.  Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.

Authors:  Ann Marie Kaukonen; Ben J Boyd; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more
  5 in total

1.  Development and Characterization of Celecoxib Solid Self-nanoemulsifying Drug Delivery Systems (S-SNEDDS) Prepared Using Novel Cellulose-Based Microparticles as Adsorptive Carriers.

Authors:  Fabian-Pascal Schmied; Alexander Bernhardt; Victor Baudron; Birte Beine; Sandra Klein
Journal:  AAPS PharmSciTech       Date:  2022-08-03       Impact factor: 4.026

Review 2.  Self-Emulsifying Granules and Pellets: Composition and Formation Mechanisms for Instant or Controlled Release.

Authors:  Ioannis Nikolakakis; Ioannis Partheniadis
Journal:  Pharmaceutics       Date:  2017-11-03       Impact factor: 6.321

3.  A Customized Screening Tool Approach for the Development of a Self-Nanoemulsifying Drug Delivery System (SNEDDS).

Authors:  Fabian-Pascal Schmied; Alexander Bernhardt; Andrea Engel; Sandra Klein
Journal:  AAPS PharmSciTech       Date:  2021-12-27       Impact factor: 3.246

4.  Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design.

Authors:  Yoon Tae Goo; Sangkil Lee; Ji Yeh Choi; Min Song Kim; Gi Hyeong Sin; Sun Ho Hong; Chang Hyun Kim; Seh Hyon Song; Young Wook Choi
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 5.  Biopharmaceutical insights of particulate emulsified systems - a prospective overview.

Authors:  Jyothshna Devi Katamreddy; Prasanna Raju Yalavarthi; Subba Rao D; Sowjanya Battu; Jaya Preethi Peesa
Journal:  Lipids Health Dis       Date:  2018-05-10       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.